MORGEN SHAFF: Open Payments
NPI 1396873105 · PARKER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$509 in 23 payments from 8 companies in 2025. Trend: 2023 $867 · 2024 $557 · 2025 $509
Food & beverage: $509
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $151 |
| Ipsen Biopharmaceuticals, Inc | 4 | $109 |
| Collegium Pharmaceutical, Inc. | 3 | $56 |
| Saluda Medical Americas, Inc. | 3 | $56 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $35 |
| Bioventus LLC | 1 | $14 |
Products named: Dysport, BOTOX, Belbuca, Evoke, QULIPTA, Symbravo, UBRELVY, RELISTOR.
Industry payments across CO — which companies pay providers there.
